Skip to main content
PMC home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1980 Mar;70(3):264–267. doi: 10.2105/ajph.70.3.264

The epidemic of endometrial cancer: a commentary.

H Jick, A M Walker, K J Rothman
PMCID: PMC1619376  PMID: 7356090

Abstract

Vital statistics show that a rise in incidence of endometrial cancer began in the mid-1960s on the West Coast of the United States. This rise was continuous and reached a peak in 1975. Elsewhere, incidence rates for endometrial cancer rose during the 1970s. It now seems evident that much of the rise in all areas of the country was due to replacement estrogen treatment. We estimated from data obtained from the Commission on Professional and Hospital Activities-Professional Activity Study of Ann Arbor, Michigan, that over 15,000 cases of endometrial cancer were caused by replacement estrogens during the five-year period 1971--1975 alone. This represents one of the largest epidemics of serious iatrogenic disease that has ever occurred in this country. With the substantial fall in estrogen sales starting in January 1976, there has been an associated decline in the incidence rates of endometrial cancer nationwide.

Full text

PDF
267

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Antunes C. M., Strolley P. D., Rosenshein N. B., Davies J. L., Tonascia J. A., Brown C., Burnett L., Rutledge A., Pokempner M., Garcia R. Endometrial cancer and estrogen use. Report of a large case-control study. N Engl J Med. 1979 Jan 4;300(1):9–13. doi: 10.1056/NEJM197901043000103. [DOI] [PubMed] [Google Scholar]
  2. Austin D. F., Roe K. M. Increase in cancer of the corpus uteri in the San Francisco-Oakland standard metropolitan statistical area, 1960--75. J Natl Cancer Inst. 1979 Jan;62(1):13–16. [PubMed] [Google Scholar]
  3. Feinstein A. R., Horwitz R. I. A critique of the statistical evidence associating estrogens with endometrial cancer. Cancer Res. 1978 Nov;38(11 Pt 2):4001–4005. [PubMed] [Google Scholar]
  4. Gray L. A., Sr, Christopherson W. M., Hoover R. N. Estrogens and endometrial carcinoma. Obstet Gynecol. 1977 Apr;49(4):385–389. [PubMed] [Google Scholar]
  5. Greenwald P., Caputo T. A., Wolfgang P. E. Endometrial cancer after menopausal use of estrogens. Obstet Gynecol. 1977 Aug;50(2):239–243. [PubMed] [Google Scholar]
  6. Homesley H. D., Boronow R. C., Lewis J. L., Jr Treatment of adenocarcinoma of the endometrium at Memorial-James Ewing Hospitals, 1949-1965. Obstet Gynecol. 1976 Jan;47(1):100–105. [PubMed] [Google Scholar]
  7. Horwitz R. I., Feinstein A. R. Alternative analytic methods for case-control studies of estrogens and endometrial cancer. N Engl J Med. 1978 Nov 16;299(20):1089–1094. doi: 10.1056/NEJM197811162992001. [DOI] [PubMed] [Google Scholar]
  8. Inman W. H., Adelstein A. M. Rise and fall of asthma mortality in England and Wales in relation to use of pressurised aerosols. Lancet. 1969 Aug 9;2(7615):279–285. doi: 10.1016/s0140-6736(69)90051-8. [DOI] [PubMed] [Google Scholar]
  9. Jick H., Walker A. M., Spriet-Pourra C. Postmarketing follow-up. JAMA. 1979 Nov 23;242(21):2310–2314. [PubMed] [Google Scholar]
  10. Jick H., Watkins R. N., Hunter J. R., Dinan B. J., Madsen S., Rothman K. J., Walker A. M. Replacement estrogens and endometrial cancer. N Engl J Med. 1979 Feb 1;300(5):218–222. doi: 10.1056/NEJM197902013000502. [DOI] [PubMed] [Google Scholar]
  11. Jones W. E., Kanner H. M., Kanner H. H., Benson C. Adenocarcinoma of the endometrium. Twenty-five years' experience in private practice. Am J Obstet Gynecol. 1972 Jun 15;113(4):549–557. [PubMed] [Google Scholar]
  12. Kinlen L. J., Doll R. Trends in mortality from cancer of the uterus in Canada and in England and Wales. Br J Prev Soc Med. 1973 Aug;27(3):146–149. doi: 10.1136/jech.27.3.146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kistner R. W. Estrogens and endometrial cancer. Obstet Gynecol. 1976 Oct;48(4):479–482. [PubMed] [Google Scholar]
  14. Lyon J. L., Gardner J. W. The rising frequency of hysterectomy: its effect on uterine cancer rates. Am J Epidemiol. 1977 May;105(5):439–443. doi: 10.1093/oxfordjournals.aje.a112402. [DOI] [PubMed] [Google Scholar]
  15. Mack T. M., Pike M. C., Henderson B. E., Pfeffer R. I., Gerkins V. R., Arthur M., Brown S. E. Estrogens and endometrial cancer in a retirement community. N Engl J Med. 1976 Jun 3;294(23):1262–1267. doi: 10.1056/NEJM197606032942304. [DOI] [PubMed] [Google Scholar]
  16. Marrett L. D., Elwood J. M., Epid S. M., Meigs J. W., Flannery J. T. Recent trends in the incidence and mortality of cancer of the uterine corpus in Connecticut. Gynecol Oncol. 1978 Apr;6(2):183–195. doi: 10.1016/0090-8258(78)90021-5. [DOI] [PubMed] [Google Scholar]
  17. McDonald T. W., Annegers J. F., O'Fallon W. M., Dockerty M. B., Malkasian G. D., Jr, Kurland L. T. Exogenous estrogen and endometrial carcinoma: case-control and incidence study. Am J Obstet Gynecol. 1977 Mar 15;127(6):572–580. doi: 10.1016/0002-9378(77)90351-9. [DOI] [PubMed] [Google Scholar]
  18. Ng A. B., Reagan J. W. Incidence and prognosis of endometrial carcinoma by histologic grade and extent. Obstet Gynecol. 1970 Mar;35(3):437–443. [PubMed] [Google Scholar]
  19. Oral contraceptives and venous thromboembolic disease, surgically confirmed gallbladder disease, and breast tumours. Report from the Boston Collaborative Drug Surveillance Programme. Lancet. 1973 Jun 23;1(7817):1399–1404. [PubMed] [Google Scholar]
  20. Smith A. L. Editorial: Ammonia disposal in Reye's syndrome. N Engl J Med. 1976 Apr 15;294(16):897–898. doi: 10.1056/NEJM197604152941608. [DOI] [PubMed] [Google Scholar]
  21. Smith D. C., Prentice R., Thompson D. J., Herrmann W. L. Association of exogenous estrogen and endometrial carcinoma. N Engl J Med. 1975 Dec 4;293(23):1164–1167. doi: 10.1056/NEJM197512042932302. [DOI] [PubMed] [Google Scholar]
  22. Walker A. M., Jick H. Cancer of the corpus uteri: increasing incidence in the United States, 1970--1975. Am J Epidemiol. 1979 Jul;110(1):47–51. doi: 10.1093/oxfordjournals.aje.a112786. [DOI] [PubMed] [Google Scholar]
  23. Walker A. M., Jick H. Temporal and regional variation in hysterectomy rates in the United States, 1970--1975. Am J Epidemiol. 1979 Jul;110(1):41–46. doi: 10.1093/oxfordjournals.aje.a112785. [DOI] [PubMed] [Google Scholar]
  24. Weiss N. S., Szekely D. R., Austin D. F. Increasing incidence of endometrial cancer in the United States. N Engl J Med. 1976 Jun 3;294(23):1259–1262. doi: 10.1056/NEJM197606032942303. [DOI] [PubMed] [Google Scholar]
  25. Weiss N. S., Szekely D. R., English D. R., Schweid A. I. Endometrial cancer in relation to patterns of menopausal estrogen use. JAMA. 1979 Jul 20;242(3):261–264. [PubMed] [Google Scholar]
  26. Ziel H. K., Finkle W. D. Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med. 1975 Dec 4;293(23):1167–1170. doi: 10.1056/NEJM197512042932303. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES